Authors:
HEHLMANN R
HEIMPEL H
HASFORD J
KOLB HJ
PRALLE H
HOSSFELD DK
QUEISSER W
LOFFLER H
HEINZE B
GEORGII A
VONWUSSOW P
BARTRAM C
GRIESSHAMMER M
BERGMANN L
ESSERS U
FALGE C
HOCHHAUS A
QUEISSER U
SICK C
MEYER P
SCHMITZ N
VERPOORT K
EIMERMACHER H
WALTHER F
WESTERHAUSEN M
KLEEBERG UR
HEILEIN A
KABISCH A
BARZ C
ZIMMERMANN R
MEURET G
TICHELLI A
BERDEL WE
KANZ L
ANGER B
TIGGES FJ
SCHMID L
BROCKHAUS W
ZANKOVICH R
SCHLAFER U
WEISSENFELS I
MAINZER K
TOBLER A
PERKER M
HOHNLOSER J
MESSENER D
THIELE J
BUHR T
ANSARI H
Citation: R. Hehlmann et al., RANDOMIZED COMPARISON OF BUSULFAN AND HYDROXYUREA IN CHRONIC MYELOGENOUS LEUKEMIA - PROLONGATION OF SURVIVAL BY HYDROXYUREA, Blood, 82(2), 1993, pp. 398-407
Authors:
HEHLMANN R
HEIMPEL H
HASFORD J
KOLB HJ
HOSSFELD DK
HEINZE B
HOCHHAUS A
PRALLE H
QUEISSER W
LOFFLER H
ANSARI H
Citation: R. Hehlmann et al., RANDOMIZED COMPARISON OF INTERFERON-ALPHA VS BUSULFAN - PROLONGATION OF SURVIVAL BY INTERFERON-ALPHA IN CHRONIC PHASE CML, Blood, 82(10), 1993, pp. 10000330-10000330
Authors:
SCHREZENMEIER H
SPATHSCHWALBE E
DRECHSLER S
FARBER L
STROMEYER P
PORZSOLT F
HEIMPEL H
RAGHAVACHAR A
Citation: H. Schrezenmeier et al., PHASE-I TRIALS OF INTERLEUKIN-6 (IL-6) IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA (RCC) AND PATIENTS WITH APLASTIC-ANEMIA (AA) - EFFECTS OF LONG-TERM APPLICATION AND DIFFERENCES OF HEMATOPOIETIC RESPONSE TO IL-6 IN PATIENTS WITH NORMAL HEMATOPOIESIS VERSUS PATIENTS WITH APLASTIC-ANEMIA, Blood, 82(10), 1993, pp. 10000368-10000368
Authors:
VONWUSSOW P
HEHLMANN R
NOLTE KU
JAKSCHIES D
HOCHHAUS T
WITTE T
ANSARI H
HASFORD J
PRUMMER O
HEIMPEL H
DEICHER H
Citation: P. Vonwussow et al., RIFN-ALPHA-2A (ROFERON) IS MORE IMMUNOGENIC THAN RIFN-ALPHA-2B (INTRON-A) IN PATIENTS WITH CML, Blood, 82(10), 1993, pp. 10000378-10000378